drugset / Trial / NCT00004688
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
Treatment
Summary
OBJECTIVES: I. Assess the clinical response of patients with refractory or recurrent brain neoplasms treated with carmustine, streptozocin, and mercaptopurine.
Timeline
- Start
- 1996-08
- Primary completion
- —
- Completion
- 1998-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MERCAPTOPURINE ANHYDROUS | Small molecule | — | Intravenous |
| Subject | carmustine | Small molecule | — | — |
| Subject | streptozocin | Small molecule | — | Intravenous |